FDA establishes center of excellence for compounded drugs
The FDA said it has established a Compounding Quality Center of Excellence to improve the quality and safety of compounded medications by offering educational programs and other learning tools to outsourcing facilities. "While engagement is voluntary, this initiative will provide an increased awareness and understanding of common issues and provide innovative ways to address challenges outsourcing facilities may face," according to Center for Drug Evaluation and Research Director Janet Woodcock. European Pharmaceutical Review (UK) (1/7)
Read full article now.
Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!